LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche Showcases Innovative Laboratory Solutions and Digital Diagnostics

By LabMedica International staff writers
Posted on 21 May 2023
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)
Image: The cobas 5800 molecular diagnostics system expands access to testing and improves patient care (Photo courtesy of Roche Diagnostics)

Roche Diagnostics (Basel, Switzerland) is showcasing innovative laboratory solutions and digital diagnostics through - "Innovation Past, Present and Future" at this year's WorldLab-EuroMedLab 2023 in Rome, Italy, 21-25 May. Attendees can experience first-hand Roche's latest technological advancements in lab automation, serum work area, molecular and point of care solutions, and discover how the company is transforming patient care through advancements in breakthrough high-medical value diagnostic and digital solutions.

At the 2023 EuroMedLab Congress, Roche is featuring new innovations, such as several molecular systems from the growing PCR portfolio – the cobas 5800 and the new LightCycler PRO System, which will be launched later this year. A prototype for the new cobas Mass Spec system is being unveiled, bringing mass spectrometry into the routine testing environment. The system complements the serum work area portfolio, allowing healthcare communities to benefit in the future from an extended diagnostic platform offering clinical chemistry, heterogeneous immunoassays, and mass spectrometry.

The new cobas connection modules (CCM Vertical), a flexible modular system that makes effective utilization of lab space and seamlessly integrates into the existing cobas connection modules, improving lab efficiency, is also being featured at the industry event. Roche is also introducing its navify digital solutions to the laboratory community that are designed to fulfill the laboratories' need for seamless and secure connectivity between systems, instruments and even devices from different providers, as well as empowering lab leaders to drive operational efficiencies and help clinicians gain greater medical insights.

"With the ever-changing needs of the healthcare system, laboratories, and clinicians are expected to optimize laboratory operations and efficiencies while improving patient care," said Ann Costello, Head of Roche Diagnostics Solutions at Roche Diagnostics. "We are pleased to present the next generation of innovative solutions that simplify and streamline testing for laboratories of all sizes, throughputs, and disciplines while supporting clinical decision-making to improve patient care."

"Laboratories have a unique opportunity to connect siloed data across systems and points of care for greater insights," said Moritz Hartmann, Head of Roche Information Solutions at Roche Diagnostics. "At Roche, we are working closely together with lab leaders to enable more patient-centered care. Our navify portfolio of integrated digital solutions enables open digital ecosystems that connect to innovations, drive operational efficiencies, and generate actionable insights for improved patient care."

Related Links:
Roche Diagnostics 

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more